<DOC>
	<DOCNO>NCT01786109</DOCNO>
	<brief_summary>Irritable bowel syndrome ( IBS ) affect 15 % U.S. population . There still effective safe medication approve treatment abdominal pain associate bowel symptom IBS . This study investigate effect approve medication , Dronabinol , movement food stomach colon subject history diarrhea-predominant Irritable Bowel Syndrome ( D-IBS ) .</brief_summary>
	<brief_title>Effect Cannabinoid Agonist Colonic Sensory Functions Patients With Irritable Bowel Syndrome</brief_title>
	<detailed_description>Irritable bowel syndrome ( IBS ) affect 15 % U.S. population . Despite increase understanding pathophysiology IBS , effective medication approve treatment abdominal pain associate IBS . Cannabinoid receptor ( CBR ) cholinergic neuron brain stem , stomach colon . A cannabinoid receptor 1 ( CB1 ) antagonist , rimonabant , effective induction weight loss ; however , mechanism benefit unclear . Human study lab show CBR agonist , dronabinol , inhibit gastric colonic motility , may alter appetite satiation obesity , may potential treatment IBS . The overall focus study mechanism involve modulation gastric colonic motor sensory function cannabinoid receptor ( CBR ) health IBS . CB1 receptor also involved nociception mediate inflammation increasingly recognize potential pathophysiological mechanism IBS . All participant undergo follow procedure : 1 . Documentation eligibility , screen questionnaire physical examination , include exclusion rectal evacuation disorder standard clinical evaluation within past 12 month ; important ensure diarrhea secondary `` retention overflow '' . 2 . Bowel preparation PEG electrolyte-containing oral colonic lavage solution , follow 12 hour fast . 3 . Colonic test compliance , tone , motility sensation measurement . Colonic compliance , fast tone , sensory threshold sensory rating response random-order phasic distension perform treatment administer . Then medication ingest , 60 minute , study perform compliance , fast tone , sensory threshold sensory rating response random-order phasic distension . Participants also fill response questionnaire ( use 100 mm VAS scale ) describe sense tiredness , peace , worry activity time measurement sensation . Finally , participant ingest standard chocolate 1000 kcal milkshake meal , postprandial colonic tone motility measure one hour . 4 . With appropriate consent , venous blood sample obtain participant DNA extraction ; use ongoing pharmacogenomics study . Note : This study relate NCT01253408 , part A protocol . Part A explored effect dronabinol gastric colonic motor function .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<mesh_term>Cannabinoid Receptor Agonists</mesh_term>
	<criteria>Age 1875 year Positive IBS symptoms Rome III criteria No prior abdominal surgery ( except appendectomy cholecystectomy Score 10 less either Anxiety Depression Hospital Anxiety/Depression Inventory Patients significant depression ( score great 10 Hospital Depression Inventory Patients anxiety ( score great 10 Hospital Anxiety Inventory . However , patient stable dos selective serotonin inhibitor ( SSRIs ) low dose tricyclic antidepressant eligible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>anandamide</keyword>
	<keyword>cannabinoid</keyword>
	<keyword>fatty acid amide hydrolase</keyword>
	<keyword>gastric</keyword>
	<keyword>motility</keyword>
	<keyword>small bowel</keyword>
	<keyword>sensory</keyword>
	<keyword>motor</keyword>
</DOC>